Colston K, Colston M J, Feldman D
Endocrinology. 1981 Mar;108(3):1083-6. doi: 10.1210/endo-108-3-1083.
In this study we demonstrate the presence of specific, high-affinity receptors for 1,25-dihydroxyvitamin D3 in malignant melanoma. Receptors are present both in cultured melanoma cells and in melanoma tumor tissue produced by inoculation of cells into athymic rats. The receptor sediments at 3.25 on sucrose density gradients, possesses a preferential affinity for 1,25-(OH)2D3 and has an apparent Kd of 0.18 nM by Scatchard analysis. We also demonstrate that human melanoma cells are responsive to 1,25-(OH)2D3 in vitro. Inclusion of 1,25-(OH)2D3 in the culture medium produced a marked increase in cell doubling time. This inhibitory effect of the hormone on melanoma cell proliferation was dose-related and represents the first demonstration of a 1,25-(OH)2D3 mediated action on tumor cells.
在本研究中,我们证明了恶性黑色素瘤中存在1,25 - 二羟维生素D3的特异性高亲和力受体。受体存在于培养的黑色素瘤细胞以及将细胞接种到无胸腺大鼠体内产生的黑色素瘤肿瘤组织中。该受体在蔗糖密度梯度中沉降系数为3.25,对1,25 - (OH)2D3具有优先亲和力,通过Scatchard分析其表观解离常数为0.18 nM。我们还证明了人黑色素瘤细胞在体外对1,25 - (OH)2D3有反应。在培养基中加入1,25 - (OH)2D3会使细胞倍增时间显著增加。该激素对黑色素瘤细胞增殖的这种抑制作用与剂量相关,并且首次证明了1,25 - (OH)2D3对肿瘤细胞的介导作用。